Sponsor
Corflow Therapeutics AG
Neuhofstrasse 3d, 6340
About the sponsor
Corflow Therapeutics AG focuses on ST-elevated myocardial infarction and related acute coronary syndrome presentations, with attention to patients experiencing microvascular obstruction after coronary reperfusion.
- STEMI
- STEACS
- Microvascular obstruction
The sponsor's clinical interest centers on cardiovascular injury linked to impaired microcirculation and the treatment of coronary complications following acute ischemic events.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.